Lightcast Announces Limited Commercial Release of Envisia™ Single-Cell Functional Analysis Platform for Antibody Discovery
Lightcast Discovery Ltd., a pioneering life science tools company, today announced the limited commercial release of its Envisia™ benchtop platform — a breakthrough droplet-based, single-cell functional analysis system designed to accelerate antibody discovery and development. The company will debut the instrument at booth #711 and present new data from its technology access program at the Essential Protein and Antibody Engineering Summit (PEGS), taking place May 12-16, 2025, in Boston.
